Similarly, JAM-B, a protein involved in synaptic adhesion, lymphocyte transendothelial migration [21], and vascular inflammation [59], was down-regulated in the plasma and CSF of AD patients and the plasma of MCI patients compared with cognitively normal Aβ- controls. Here, JAM2 is linked to Alzheimer disease.